Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000102 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 11, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
33,000
Total Value
$2,456,140.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 7, 2026 | Exercise/Conversion | 5,000 | $10.39 | $51,950.00 | 5,000 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 7, 2026 | Sale | 5,000 | $104.47 | $522,350.00 | 0 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 7, 2026 | Sale | 8,000 | $104.38 | $835,040.00 | 19,360 | Indirect | By Sessions LLC | View Details | |
Director | Common Stock | โ | Aug 7, 2026 | Sale | 10,000 | $104.68 | $1,046,800.00 | 9,360 | Indirect | By Sessions LLC | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Aug 7, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 45,000 | Direct | โ | View Details |